Built by physicians for physicians

Coffee MicroCaps 18 March 2021 Innovative provider of cloud-based medical imaging software solutions

IMEXHS LTD | (ASX:IME) 2 Built by physicians for physicians

2012 2016 2018 2020 Founded in Release zero IMEXHS lists Launched Aquila in by two Professors of footprint WEB on ASX the Cloud, open US Neuroradiology & viewer office, certification in and EU, radiology software new partners engineer

2015 2017 2019 Expand Implement solutions Receive FDA Clearance in outside across 200 USA, new medical verticals Colombia healthcare sites & AI tools, new markets

IMEXHS LTD | (ASX:IME) 3 Expanding global footprint

Spain

USA 15 countries >250 sites El Salvador Australia Costa Rica Colombia >2,100 radiologists 23 distributors Brazil 1/3 of team in Paraguay software development Chile Uruguay

IMEXHS currently operating

Argentina Agreement being negotiated

4 IMEXHS LTD | (ASX:IME) Leading innovator in medical imaging

TM • Multi-tenant architecture, cloud- • HIRUKO platform provides based medical imaging software solutions for all complexity levels

• Subscription model with high • Aquila in the Cloud standardised recurring revenue from multi-year radiology solution contracts

• Multiple distribution channels across • Developing AI tools - large proprietary 15 countries database of 940m stored images

IMEXHS LTD | (ASX:IME) 5 Multiple runways for growth

Aquila Custom Aquila in the Cloud Other Medical Verticals

• Standardised • Alula – pathology • Aquila customised radiology solution radiology offering • Anteros – cardiology • 1-2 year contracts on • 5-year contracts on average • Extend into other average verticals • Volume-based model • Subscription model

Expanding into new geographies including US and Brazil

IMEXHS LTD | (ASX:IME) 6 HIRUKOTM medical imaging platform

Advanced Stella Vital Alma Braviz Post-processing AI 3D ADv 3D Basic

Enterprise Aquila Alula Anteros Imaging Radiology Pathology Cardiology

HIRUKOTM Universal Core Platform Portals Multi-Tenancy PACS/VNA Viewer

Nuance 360

IMEXHS LTD | (ASX:IME) *Components in blue represent IMEXHS proprietary technology 7 End-to-end modular imaging solution

Scan scheduled Uploaded Archived on our 1)Business Manages via our to our platform cloud-based Intelligence Billing platform platform } 2)Statistical Data

3. 4. 5. 1. 2. Radiologist Referring Physician Billing Physician Patient has interprets scanned reviews images via (where requests patient scheduled scan images Referring applicable) scan (Tele-Radiology1) Physician Portal

1 Teleradiology - radiology concerned with the transmission of digitised medical images (as X-rays, CT scans, and sonograms) over electronic networks and with the interpretation of the transmitted images for diagnostic purposes

IMEXHS LTD | (ASX:IME) 8 Aquila in the Cloud

• Aquila in the Cloud, standardised radiology solution, launched in May 2020 $1,200k

• Provides small and medium-sized customers with 54 low-cost, rapidly deployed product offering $945k

41 • At 31 Dec 2020, 41 deals signed, estimated ARR $675k contribution of $945k. This increased to 48 deals at 24 February 2021. $473k 28 $400k • At 16 March 2021, 54 deals signed with ARR 17 contribution of $1.2m. 12 • Distribution via growing partner network and online marketplaces Sept Oct Nov Dec Mar

• Strong pipeline of new opportunities New contracts (cumulative) ARR contribution

IMEXHS LTD | (ASX:IME) 9 Range of solutions for AiC customers

LITE PRO ULTIMATE

Multiplatform Unlimited Users Unlimited Exams 100% Web Platform Modality Worklist Management Scheduling VNA | PACS Archiving Digital Signature in Reports SMS notifications Web Viewer VR Web (Reporting) (*) Patient Admission Results Distribution Results Distribution Questionnaire Standard KPIs Patient & Physician Portal Business Intelligence (BI)

IMEXHS LTD | (ASX:IME) 10 Multiple distribution channels

• Distributors partners represent important • Established new distribution channel in April sales channel for both Aquila Custom and 2020 with acceptance on Ingram’s Micro Cloud Aquila in the Cloud marketplace

DISTRIBUTION CHANNELS

DIRECT SALES DISTRIBUTORS • Mainly in Colombia, US • Agreements with distributor partners • Global cloud marketplace • Low risk go-to-market strategy

Private Hospitals & Clinics Public Hospitals & Clinics Private Practices

IMEXHS LTD | (ASX:IME) 11 Developing AI capabilities

• Images almost doubled to 940m reflecting full year of Colsubsidio contract Number of Images Stored (m)

940 • Important test bed for the development and training of AI tools

• Developed Stella AI which identifies normal and 488 pathological radiological patterns in chest x-

rays 231

99 • Released non-imaging AI tools in natural 32 language processing 2016 2017 2018 2019 2020

IMEXHS LTD | (ASX:IME) 12 FY20 Financial Highlights

Sales Revenue of ARR of EBITDA of $10.9m $10.1m ($1.3m) Up 41% yoy1, new contract Up 19% yoy, 33% higher on a Improvement of $3.3m, wins & renewals constant currency basis $2.5m on like for like basis3

Underlying EBITDA4 of Recurring revenue of Closing cash of $8.5m $10.8m ($0.7m) 2 Improvement of $3.8m, Up 29% yoy $7.1m at 31 Dec 2019 $3.0m on a like for like basis3

1. Sales revenue up 59% on a constant currency basis 2. Recurring revenue up 45% on a constant currency basis 3. Adjusting for the impact of software capitalisation policy adopted in FY20 IMEXHS LTD | (ASX:IME) 4. Refer Slide 20 of FY20 Investor Presentation for Underlying EBITDA reconciliation 13 5. FY20 results are preliminary / unaudited Strong growth in ARR

• 2016201720182019Annualised2020 Recurring Revenue Annual Recurring Revenue (ARR) of 12 $10.1m, up 19% yoy (33% on constant currency basis) 10

8 • Recent contract wins include Gables Radiology in the US, Keralty 6

$ $ m (Colombia), and Laboratorios Santa 4 Maria (Mexico)

2 • Contract renewals and extensions 0 include National Police Hospital in 2016 2017 2018 2019 2020 Bogotá (Colombia) and Corominas y Spot Not Yet Billing Constant Currency Not Yet Billing Castillo (Mexico)

IMEXHS LTD | (ASX:IME) 14 INDUSTRY TRENDS: Healthcare IT sector

Increasing use of Large, rapidly radiological Chronic global Shift from client growing but highly Increased proportion techniques in wider radiologist shortage server architecture to fragmented global of the value chain clinical applications, driving demand for fully web-based cloud medical imaging coming from AI demand for central teleradiology solutions sector storage of images

STRATEGIC PRIORITIES: Benefiting from industry tailwinds

‘Land & expand’ Geographic Teleradiology Large AI image library strategy with multiple Aquila in the Cloud expansion across solution allows and radiology verticals including low touch multiple markets, radiologists to access services drive cardiology and deployment model leverage specialist images from any development of AI pathology, VNA for small clinics distributors device or location tools capability

IMEXHS LTD | (ASX:IME) 15 2021 Product Roadmap

AQUILA 4.0 with new Alula Marketplace, the Other medical verticals AI Algorithms features and functions world’s first dedicated • Dental Imaging • Automatic detection and orientated to US and pathology marketplace platform segmentation of lung Australian markets workflow program • Veterinary areas with consolidation Information System and ground glass opacities on CT scans • Automatic selection from a radiologist worklist and posterior rendering of Democratising access to high-tech functional MRI and DTI medical imaging platforms tractography

IMEXHS LTD | FY20 FINANCIAL RESULTS (ASX:IME) 16 FY21 Outlook

Aquila in the Cloud (AiC) – Leverage 2021 trading to date in line with distribution partners to convert strong Company expectations interest across all markets

Improved outlook for key markets US – build presence with AiC offering despite second waves of COVID-19 and via online marketplaces

New markets – open office in Brazil On track to achieve monthly run rate and explore opportunities in EU EBITDA breakeven by December 2021

IMEXHS LTD | (ASX:IME) 17 Q&A

Investor enquiries: [email protected] WWW.IMEXHS.COM

18 Disclaimer

The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and conditions set out in this notice.

The Recipient should not treat the Information as advice relating to legal, taxation, financial product or investment matters and should consult their own advisers. This Presentation does not purport to contain all the information that a prospective investor may require. The Information may not be appropriate for all persons and it is not possible for ImExHS Limited to have regard to the investment objectives, financial situation and particular needs of each Recipient who reads or uses the Information . Accordingly, no recommendation or expression of opinion is contained within the Information. Further, no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the Information, including the likelihood of achievement or reasonableness or any forecasts, prospects or returns contained in the Information. Before acting in reliance on any Information, the Recipient should conduct their own investigation and analysis in relation to the investment opportunity presented by this Presentation and should check the accuracy, reliability and completeness of the Information and obtain independent and specific advice from appropriate professional advisers.

Statements contained in the Information, particularly those regarding possible or assumed future performance or potential growth, prospects or projections of ImExHS Limited are, or may be, forward looking statements. Such statements relate to future events and expectations and, as such, involve known and unknown risks, uncertainties and contingencies. The Information may also be subject to clarification and change and ImExHS Limited may in its absolute discretion, but without being under any obligation to do so, update, amend or supplement the Information. The Information is for informational purposes only and does not constitute an offer to issue, or arrange to issue, securities or other financial products. The Information is not, and should not be construed to be, a Prospectus.

To the maximum extent permitted by law none of ImExHS Limited or its respective employees, agents or consultants nor any other person accepts any liability, including, without limitation, any liability arising out of fault of negligence, for any loss arising from the use of the Information.

19